Antiviral diseases

Antiviral therapy for Neuroinvasive West Nile virus:  Ribavirin/Tribavirin, an antiviral drug used in the treatment of RSV infection, hepatitis C, and viral hemorrhagic fever, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 3/November/2017, 7.31 am
Antiviral therapy for Neuroinvasive West Nile virus:  Ribavirin/Tribavirin, an antiviral drug used in the treatment of RSV infection, hepatitis C, and viral hemorrhagic fever, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 3/November/2017, 7.31 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA…

read more

Antiviral therapy for HIV virus: Ribavirin/Tribavirin, an antiviral medication used in the treatment of RSV infection, hepatitis C, and viral hemorrhagic fever,  increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 31/October/2017, 10.43am
Antiviral therapy for HIV virus: Ribavirin/Tribavirin, an antiviral medication used in the treatment of RSV infection, hepatitis C, and viral hemorrhagic fever,  increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 31/October/2017, 10.43am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Biochemistry and Molecular Biophysics and Department of Microbiology and Immunology, Howard Hughes Medical Institute, Columbia University, New York, NY 10032,…

read more

Natural product-derived antiviral therapy against Neuroinvasive West Nile virus:  Andrographolide, one of the main components of Andrographis paniculata, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 25/October/2017, 11.27 pm
Natural product-derived antiviral therapy against Neuroinvasive West Nile virus:  Andrographolide, one of the main components of Andrographis paniculata, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 25/October/2017, 11.27 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA…

read more

Antiviral therapy for chikungunya (CHIKV) and Zika (ZIKV) viruses: Andrographolide, isolated from Andrographis paniculata, increases spermidine/spermine N1-acetyltransferase (SAT) expression, depletes spermidine and Spermine levels, and restricts Chikungunya and Zika viruses replication via up regulation of its target gene, 19/October/2017, 10.25 am
Antiviral therapy for chikungunya (CHIKV) and Zika (ZIKV) viruses: Andrographolide, isolated from Andrographis paniculata, increases spermidine/spermine N1-acetyltransferase (SAT) expression, depletes spermidine and Spermine levels, and restricts Chikungunya and Zika viruses replication via up regulation of its target gene, 19/October/2017, 10.25 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Viral Populations and Pathogenesis Unit, Institut Pasteur, CNRS UMR 3569, 25–28 rue du Dr. Roux, 75724 Paris Cedex 15, France shows that…

read more

Antiviral therapy for HIV virus: Nimesulide, a drug used to relieve pain,  increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 15/October/2017, 1.14 am
Antiviral therapy for HIV virus: Nimesulide, a drug used to relieve pain,  increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 15/October/2017, 1.14 am 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Antiviral therapy for HIV virus: Nimesulide, a drug used to relieve pain,  increases Heme oxygenase 2 (HO-2) expression,…

read more

Antiviral therapy for Neuroinvasive West Nile virus: Rifampicin, an antibiotic used in the treatment of tuberculosis, leprosy, and Legionnaire’s disease, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 15/October/2017, 1.06 am
Antiviral therapy for Neuroinvasive West Nile virus: Rifampicin, an antibiotic used in the treatment of tuberculosis, leprosy, and Legionnaire’s disease, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 15/October/2017, 1.06 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109,…

read more
Start Typing